BRPI0508858A - solução oftálmica incluindo carboximetilcelulose de sódio e hidroxipropilmetilcelulose - Google Patents

solução oftálmica incluindo carboximetilcelulose de sódio e hidroxipropilmetilcelulose

Info

Publication number: BRPI0508858A
Authority: BR; Brazil
Prior art keywords: ophthalmic solution; solution including; hydroxypropyl methylcellulose; sodium carboxymethylcellulose; including sodium
Prior art date: 2004-03-17

Application number

BRPI0508858-5A

Other languages

English (en)

Portuguese (pt)

Inventor

Fu-Pao Tsao

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-17

Filing date

2005-03-16

Publication date

2007-08-28

2005-03-16 Application filed by Novartis Ag filed Critical Novartis Ag

2007-08-28 Publication of BRPI0508858A publication Critical patent/BRPI0508858A/pt

Links

229940054534 ophthalmic solution Drugs 0.000 title abstract 3
239000002997 ophthalmic solution Substances 0.000 title abstract 3
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 title abstract 2
239000001768 carboxy methyl cellulose Substances 0.000 title abstract 2
239000001866 hydroxypropyl methyl cellulose Substances 0.000 title abstract 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 title abstract 2
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 title abstract 2
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 title abstract 2
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 title abstract 2
229920001027 sodium carboxymethylcellulose Polymers 0.000 title abstract 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 6
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1
230000002335 preservative effect Effects 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

BRPI0508858-5A 2004-03-17 2005-03-16 solução oftálmica incluindo carboximetilcelulose de sódio e hidroxipropilmetilcelulose BRPI0508858A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55388004P	2004-03-17	2004-03-17
PCT/EP2005/002804 WO2005089715A1 (en)	2004-03-17	2005-03-16	Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose

Publications (1)

Publication Number	Publication Date
BRPI0508858A true BRPI0508858A (pt)	2007-08-28

Family

ID=34962605

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0508858-5A BRPI0508858A (pt)	2004-03-17	2005-03-16	solução oftálmica incluindo carboximetilcelulose de sódio e hidroxipropilmetilcelulose

Country Status (15)

Country	Link
US (4)	US20050244509A1 (es)
EP (1)	EP1732511A1 (es)
JP (1)	JP2007529458A (es)
KR (1)	KR20070005625A (es)
CN (1)	CN1933812A (es)
AU (1)	AU2005224012B2 (es)
BR (1)	BRPI0508858A (es)
CA (1)	CA2557795A1 (es)
EC (1)	ECSP066808A (es)
IL (1)	IL177725A0 (es)
MA (1)	MA28507B1 (es)
NO (1)	NO20064661L (es)
RU (1)	RU2006136092A (es)
TN (1)	TNSN06293A1 (es)
WO (1)	WO2005089715A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070048389A1 (en) *	2005-08-26	2007-03-01	Fu-Pao Tsao	Stabilized and preserved ketotifen ophthalmic compositions
US20070048388A1 (en) *	2005-08-26	2007-03-01	Fu-Pao Tsao	Stabilized and preserved ketotifen ophthalmic compositions
AR059927A1 (es)	2006-03-17	2008-05-07	Johnson & Johnson Vision Care	Metodos para la estabilizacion de composiciones inestables a la oxidacion y composiciones oftalmicas estabilizadas
US20070264226A1 (en) *	2006-05-10	2007-11-15	Karagoezian Hampar L	Synergistically enhanced disinfecting solutions
AU2013224663B2 (en) *	2007-08-31	2015-01-15	Alcon Inc.	Contact Lens Products
TWI551305B (zh) *	2007-08-31	2016-10-01	諾華公司	相對黏稠封裝溶液之用途
US20090239954A1 (en) *	2008-03-19	2009-09-24	Collins Gary L	Phosphate buffered ophthalmic solutions displaying improved efficacy
TW201127423A (en) *	2009-12-17	2011-08-16	Alcon Res Ltd	Ophthalmic solutions with improved disinfection profiles
US20150000936A1 (en) *	2011-12-13	2015-01-01	Schlumberger Technology Corporation	Energization of an element with a thermally expandable material
KR102648671B1 (ko)	2015-12-03	2024-03-19	알콘 인코포레이티드	콘택트 렌즈 포장 용액
US10561593B2 (en)	2015-12-28	2020-02-18	Johnson & Johnson Consumer Inc.	Hair growth composition and method
CN107041892B (zh) *	2016-07-12	2021-02-26	合肥九研医药科技开发有限公司	羟丙基甲基纤维素在上消化道黏膜损伤护理上的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4880601A (en) *	1985-09-27	1989-11-14	Laboratoires, P.O.S.	Hydrogen peroxide disinfecting system for contact lenses
US5607698A (en) *	1988-08-04	1997-03-04	Ciba-Geigy Corporation	Method of preserving ophthalmic solution and compositions therefor
US5888493A (en) *	1996-12-05	1999-03-30	Sawaya; Assad S.	Ophthalmic aqueous gel formulation and related methods
TWI236377B (en) *	2000-09-28	2005-07-21	Novartis Ag	Stabilized hydrogen peroxide solutions
AR038299A1 (es) *	2002-01-18	2005-01-12	Novartis Ag	Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas.

2005
- 2005-03-11 US US11/078,209 patent/US20050244509A1/en not_active Abandoned
- 2005-03-16 CN CNA2005800084792A patent/CN1933812A/zh active Pending
- 2005-03-16 AU AU2005224012A patent/AU2005224012B2/en not_active Ceased
- 2005-03-16 EP EP05716123A patent/EP1732511A1/en not_active Withdrawn
- 2005-03-16 KR KR1020067018918A patent/KR20070005625A/ko not_active Withdrawn
- 2005-03-16 BR BRPI0508858-5A patent/BRPI0508858A/pt not_active IP Right Cessation
- 2005-03-16 CA CA002557795A patent/CA2557795A1/en not_active Abandoned
- 2005-03-16 RU RU2006136092/15A patent/RU2006136092A/ru unknown
- 2005-03-16 JP JP2007503283A patent/JP2007529458A/ja active Pending
- 2005-03-16 WO PCT/EP2005/002804 patent/WO2005089715A1/en not_active Ceased
2006
- 2006-08-28 IL IL177725A patent/IL177725A0/en unknown
- 2006-08-30 EC EC2006006808A patent/ECSP066808A/es unknown
- 2006-09-15 TN TNP2006000293A patent/TNSN06293A1/en unknown
- 2006-09-27 MA MA29348A patent/MA28507B1/fr unknown
- 2006-10-13 NO NO20064661A patent/NO20064661L/no not_active Application Discontinuation
2007
- 2007-12-20 US US11/961,034 patent/US20080096978A1/en not_active Abandoned
2010
- 2010-02-19 US US12/708,749 patent/US20100143493A1/en not_active Abandoned
2012
- 2012-05-07 US US13/465,225 patent/US20120220961A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20050244509A1 (en)	2005-11-03
US20080096978A1 (en)	2008-04-24
US20100143493A1 (en)	2010-06-10
CA2557795A1 (en)	2005-09-29
TNSN06293A1 (en)	2007-12-03
RU2006136092A (ru)	2008-04-27
AU2005224012A1 (en)	2005-09-29
MA28507B1 (fr)	2007-04-03
IL177725A0 (en)	2006-12-31
AU2005224012B2 (en)	2009-07-02
US20120220961A1 (en)	2012-08-30
EP1732511A1 (en)	2006-12-20
KR20070005625A (ko)	2007-01-10
JP2007529458A (ja)	2007-10-25
CN1933812A (zh)	2007-03-21
WO2005089715A1 (en)	2005-09-29
ECSP066808A (es)	2006-11-16
NO20064661L (no)	2006-12-14

Legal Events

Date	Code	Title	Description
2009-12-22	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2010-04-13	B04C	Request for examination: application reinstated [chapter 4.3 patent gazette]
2012-05-15	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2012-10-09	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.

Publication	Publication Date	Title
CO6541634A2 (es)	2012-10-16	Composición de cereal hidrolizado
BRPI0911035B8 (pt)	2021-05-25	ativadores de pirrolidinona glicoquinase
AR088380A1 (es)	2014-05-28	Formulaciones de etanercept estabilizadas con cloruro de sodio
GEP20135907B (en)	2013-08-12	L-(piperidin-4-yl)-pyrazole derivatives as gpr 119 modulators
PE20120648A1 (es)	2012-05-31	Compuestos de 4-isopropilfenilglucitol como inhibidores de sglt1
SG155961A1 (en)	2009-10-29	Pyrazoles as 11-beta-hsd-1
GT200600084A (es)	2006-11-22	Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
NO20074391L (no)	2007-12-11	CIS-2,4,5-triaryl-imidazoliner og deres anvendelse som anti-cancer medikamenter
BRPI0717035B8 (pt)	2021-05-25	moduladores de benzotriazol cinase
CL2011001082A1 (es)	2012-02-24	Compuestos derivados de amino-tetrahidropiranos sustituidos con heterociclos, composicion farmaceutica; y uso en el tratamiento de una afeccion seleccionada de resistencia a la insulina, hiperglicemia y diabetes de tipo 2.
EA201170703A1 (ru)	2012-01-30	Производные адамантилбензамида
EA200870216A1 (ru)	2009-02-27	Амидо соединения и их применение в качестве лекарственных средств
MA33384B1 (fr)	2012-06-01	Sulfonamides hétérocycliques, leurs utilisations et compositions pharmaceutiques les contenant
GEP20146122B (en)	2014-07-25	Pharmaceutical composition
NO20083669L (no)	2008-10-27	4-aryl-2amino-pyrimidiner eller 4-aryl-2-aminoalkylpyrimidiner som jak-2-modulatorer og fremgangsmater for anvendelse derav
UY32543A (es)	2010-11-30	Análogos de isoxazol-3(2h)-ona como agentes terapéuticos
NO20091326L (no)	2009-04-01	Indazolderivater som modulatorer av interleukin-1-reseptor-assosiert kinase
ES2531009T3 (es)	2015-03-09	Análogos sustituidos de dicetopiperazina para su uso como agentes para la administración de fármacos
MX2010009922A (es)	2010-09-28	Activadores de piridazinona glucocinasa.
DE602008002567D1 (de)	2010-10-28	Neue substituierte arylsulphonylglycine, ihre herstellung und ihre verwendung als pharmazeutische zusammensetzungen
MA32787B1 (fr)	2011-11-01	Peptides antiviraux therapeutiques
BR112015014006A2 (pt)	2017-07-11	composições de cuidado oral estáveis ao peróxido
BRPI0608291A2 (pt)	2009-12-22	agente imunossupressor e agente antitumoral que compreendem composto heterocìclico como ingrediente ativo
MX2009011554A (es)	2010-01-25	Preparacion solida estable conteniendo un derivado de 4,5-epoximorfinano.
CR20120061A (es)	2012-03-06	Tableta